0001778151-19-000002.txt : 20190808 0001778151-19-000002.hdr.sgml : 20190808 20190808083225 ACCESSION NUMBER: 0001778151-19-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190808 DATE AS OF CHANGE: 20190808 EFFECTIVENESS DATE: 20190808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Seneca Therapeutics, Inc. CENTRAL INDEX KEY: 0001778151 IRS NUMBER: 824541163 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-340698 FILM NUMBER: 191007608 BUSINESS ADDRESS: STREET 1: 202 ST. ANDREWS COURT CITY: BLUE BELL STATE: PA ZIP: 19422 BUSINESS PHONE: 484-883-9725 MAIL ADDRESS: STREET 1: 202 ST. ANDREWS COURT CITY: BLUE BELL STATE: PA ZIP: 19422 D/A 1 primary_doc.xml X0708 D/A LIVE 0001778151 Seneca Therapeutics, Inc. 202 ST. ANDREWS COURT BLUE BELL PA PENNSYLVANIA 19422 484-883-9725 DELAWARE None None Corporation true 2018 Paul Hallenbeck 202 St. Andrews Court Blue Bell PA PENNSYLVANIA 19422 Executive Officer Director Pharmaceuticals Decline to Disclose 06b true 0001778151-19-000001 2019-05-15 false true true true false 0 Walter Greenblatt & Associates, LLC 129291 None None 327 St. Marks Avenue Brooklyn NY NEW YORK 11238 CA CALIFORNIA FL FLORIDA MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK PA PENNSYLVANIA WA WASHINGTON false 500000 380000 120000 false 7 35000 true 0 Sales commissions will be $35,000 if the total offering amount is sold. 90368 false Seneca Therapeutics, Inc. Paul Hallenbeck Paul Hallenbeck President 2019-08-07